Join our smart investors - Get the best stock directories in  blockchain, cannabis, crypto, AI, IoT, cleantech. Daily podcasts in cannabis and crpto. Just $99  a year

CSE New Listing - Luminor Medical Technologies Inc. (LMT); @CSE_News


November 30, 2017 ( Newswire) The common shares of Luminor Medical Technologies Inc. have been approved for listing on the CSE. Listing and disclosure documents will be available at on the trading date.

Luminor Medical Technologies operates through its two wholly owned subsidiaries - Scout Assessment Corp. and Jamaica BLU Limited. Scout Assessment Corp.'s key product is the Scout DS®, a device that has been regulatory cleared in certain markets both as a non-invasive clinical tool to assist in the identification of both prediabetes and type 2 diabetes. Jamaica BLU Limited holds the exclusive Canadian licence of all current and future cannabis commercial products developed by Rise Research Inc. Currently, Rise Research's portfolio consists of cannabis-based formulations which support patients with low libido called Jamaica blū and Jamaica pnk.


L'inscription à la cote de CSE des actions ordinaires de Luminor Medical Technologies Inc. a été approuvée.

Les documents d'inscription et de divulgation seront disponibles sur à la date de négociation.

Luminor Medical Technologies exerce ses activités par l'intermédiaire de ses deux filiales en propriété exclusive, soit Scout Assessment Corp. et Jamaica BLU Limited. Le produit phare de Scout Assessment Corp. est le Scout DS®, un dispositif qui a été autorisé sur certains marchés à la fois comme un outil clinique non invasif pour aider à l'identification du prédiabète et du diabète de type 2. Jamaica BLU Limited détient la licence canadienne exclusive de tous les produits commerciaux de cannabis actuels et futurs développés par Rise Research Inc. Actuellement, le portefeuille de Rise Research est constitué de formulations à base de cannabis qui soutiennent les patients à faible libido Jamaica jam et Jamaica pnk.

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail:

Pour toute question, pour obtenir de l'information supplémentaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel à l'adresse:

About the CSE

The Canadian Securities Exchange, or CSE, is operated by CNSX Markets Inc. Recognized as a stock exchange in 2004, the CSE began operations in 2003 to provide a modern and efficient alternative for companies looking to access the Canadian public capital markets. is a listed service provider on the Canadian Securities Exchange - A Leading Global Investor Website for Biotech Industry Stocks - investing ideas in biotechnology stocks, medical technology and life sciences

Like Biotech Stocks? View our Biotech Stocks Directory

Get News Alerts on Biotech Stocks

More Info: Newswire

This news is published on the Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: Learn more about publishing your news release on the newswire

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

Please read privacy policy: